David Shook, M.D.

David Shook, M.D.

Chief Medical Officer, Head of Research and DevelopmentatNkarta· In proxies 2023–2024

Pay in FY2024+26% from the year before · Nkarta stock -62.3% the same year

David Shook, M.D. was paid $1.9M in FY2024 (Dec), up 26%. Nkarta stock fell 62.3% that year.

Pay$100 in the stock at the end of FY22 → $42
Pay is from the Summary Compensation Table of each Nkarta proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NkartaPublic company · 3 yr
    • Chief Medical Officer, Head of Research and Development2023 – Present · 3 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?